Ho HT - Search Results

1

Monoclonal antibodies against the fusion peptide of hemagglutinin protect mice from lethal influenza A virus H5N1 infection.

Prabhu N, Prabakaran M, Ho HT, Velumani S, Qiang J, Goutama M, Kwang J. Prabhu N, et al. Among authors: ho ht. J Virol. 2009 Mar;83(6):2553-62. doi: 10.1128/JVI.02165-08. Epub 2008 Dec 24. J Virol. 2009. PMID: 19109379 Free PMC article.

2

Development of epitope-blocking ELISA for universal detection of antibodies to human H5N1 influenza viruses.

Prabakaran M, Ho HT, Prabhu N, Velumani S, Szyporta M, He F, Chan KP, Chen LM, Matsuoka Y, Donis RO, Kwang J. Prabakaran M, et al. Among authors: ho ht. PLoS One. 2009;4(2):e4566. doi: 10.1371/journal.pone.0004566. Epub 2009 Feb 24. PLoS One. 2009. PMID: 19238211 Free PMC article.

3

Rapid detection of H5N1 subtype influenza viruses by antigen capture enzyme-linked immunosorbent assay using H5- and N1-specific monoclonal antibodies.

Ho HT, Qian HL, He F, Meng T, Szyporta M, Prabhu N, Prabakaran M, Chan KP, Kwang J. Ho HT, et al. Clin Vaccine Immunol. 2009 May;16(5):726-32. doi: 10.1128/CVI.00465-08. Epub 2009 Mar 25. Clin Vaccine Immunol. 2009. PMID: 19321691 Free PMC article.

4

Combination therapy using chimeric monoclonal antibodies protects mice from lethal H5N1 infection and prevents formation of escape mutants.

Prabakaran M, Prabhu N, He F, Hongliang Q, Ho HT, Qiang J, Meng T, Goutama M, Kwang J. Prabakaran M, et al. Among authors: ho ht. PLoS One. 2009 May 22;4(5):e5672. doi: 10.1371/journal.pone.0005672. PLoS One. 2009. PMID: 19478856 Free PMC article.

5

Prophylactic and therapeutic efficacy of a chimeric monoclonal antibody specific for H5 haemagglutinin against lethal H5N1 influenza.

Prabhu N, Prabakaran M, Hongliang Q, He F, Ho HT, Qiang J, Goutama M, Lim AP, Hanson BJ, Kwang J. Prabhu N, et al. Among authors: ho ht. Antivir Ther. 2009;14(7):911-21. doi: 10.3851/IMP1413. Antivir Ther. 2009. PMID: 19918095

6

A novel peptide ELISA for universal detection of antibodies to human H5N1 influenza viruses.

Velumani S, Ho HT, He F, Musthaq S, Prabakaran M, Kwang J. Velumani S, et al. Among authors: ho ht. PLoS One. 2011;6(6):e20737. doi: 10.1371/journal.pone.0020737. Epub 2011 Jun 10. PLoS One. 2011. PMID: 21695200 Free PMC article.

7

Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors.

Hurt AC, Ho HT, Barr I. Hurt AC, et al. Among authors: ho ht. Expert Rev Anti Infect Ther. 2006 Oct;4(5):795-805. doi: 10.1586/14787210.4.5.795. Expert Rev Anti Infect Ther. 2006. PMID: 17140356 Review.

8

Cost-Effectiveness of the Pneumococcal Vaccine in the Adult Population: A Systematic Review.

Vo NX, Pham HL, Bui UM, Ho HT, Bui TT. Vo NX, et al. Among authors: ho ht. Healthcare (Basel). 2024 Dec 9;12(23):2490. doi: 10.3390/healthcare12232490. Healthcare (Basel). 2024. PMID: 39685112 Free PMC article. Review.

9

Cost-Effectiveness Analysis of Pneumococcal Vaccines in the Pediatric Population: A Systematic Review.

Vo NX, Pham HL, Bui UM, Ho HT, Bui TT. Vo NX, et al. Among authors: ho ht. Healthcare (Basel). 2024 Sep 29;12(19):1950. doi: 10.3390/healthcare12191950. Healthcare (Basel). 2024. PMID: 39408130 Free PMC article. Review.

10

Mixed active metabolites of the SNP-6 series of novel compounds mitigate metabolic dysfunction-associated steatohepatitis and fibrosis: promising results from pre-clinical and clinical trials.

Ho HT, Shih YL, Huang TY, Fang WH, Liu CH, Lin JC, Hsiang CW, Chu KM, Hsiong CH, Chen GJ, Wu YE, Hao JY, Liang CW, Hu OY. Ho HT, et al. J Transl Med. 2024 Oct 14;22(1):936. doi: 10.1186/s12967-024-05686-7. J Transl Med. 2024. PMID: 39402603 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

220 results

Search Page

Filters